Medical News

RSS

Edgewater, Haldimand sign deal to acquire supply chain services from SSW

Haldimand War Memorial Hospital and Edgewater Gardens select Shared Services West as its Preferred Supplier for Supply Chain Services.

18 Apr 2011

Flagship introduces end-to-end solutions for Medicare's reporting, recovery requirements

Flagship Services Group, Inc., a company providing expertise in Medicare compliance for insurance carriers, self-insured entities, attorneys, and state and local government agencies, today announced its unique end-to-end solutions for the compliance challenges the industry faces relating to the Centers for Medicare and Medicaid Services' reporting and Medicare Secondary Payer recovery requirements.

18 Apr 2011

Idera's gene-silencing oligonucleotide studies published in Journal of Medicinal Chemistry

Idera Pharmaceuticals, Inc. today announced the online publication in the Journal of Medicinal Chemistry of its studies of a novel class of compounds, which we refer to as gene-silencing oligonucleotides.

18 Apr 2011

Amylin reports total revenue of $152.7 million for quarter ended March 31, 2011

Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2011.

18 Apr 2011

FDA accepts Regeneron's VEGF Trap-Eye BLA for review

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has accepted for review the Company's Biologics License Application for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration.

18 Apr 2011

Prism Medical acquires Movement 2

Prism Medical Ltd., a leading provider of durable medical equipment and related services to the mobility disadvantaged, today announced the acquisition of Movement 2 Ltd., a provider of home care patient moving and handling equipment, servicing and repair in the East Midlands region of the UK.

18 Apr 2011

iOWH's semisynthetic ART enters production, distribution phase to combat malaria

The Institute for OneWorld Health, a non-profit drug development organization, announced today that its development of an alternative source of artemisinin using pioneering synthetic biology technology has successfully entered the production and distribution phase.

18 Apr 2011

Nuvo Research to acquire ZARS Pharma

Nuvo Research Inc., a pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced that it has entered into an agreement to acquire ZARS Pharma, Inc., a specialty pharmaceutical company based in Salt Lake City, Utah.

18 Apr 2011

Biotech Synergy concludes EP-2101 asset transfer, cancer epitopes related portfolio

Biotech Synergy has concluded the asset transfer of multi-epitope cancer vaccine product formerly known as EP-2101 and cancer epitopes related portfolio. Emile Loria, M.D., former President and Chief Business Officer of IDM and former President & CEO of Epimmune, is the founder of Biotech Synergy.

18 Apr 2011

True 2 Beauty launches new sexual enhancement supplements

True 2 Beauty Inc., a leading distributor of male and female sexual potency pills and liquid products in the United States, is pleased to announce the launch of a new, additional line of sexual enhancement supplements for men and women under the brand Blue Diamond and Pink Diamond.

18 Apr 2011

ETView Medical enters distribution agreement with Stopler Belgium

ETView Medical Ltd., a commercial stage medical device company traded on the Tel Aviv stock exchange, announced today that it has entered into a distribution agreement with Stopler Belgium.

18 Apr 2011

Study: Borna disease virus does not contain exact copies of genomic RNAs

Like bacteria, viruses have their own genome. The ends or termini of a viral RNA are especially interesting for virologists because they play an important role in reproduction and in the reaction of the innate immune system to the virus.

18 Apr 2011

Penile extenders represent an effective lengthening method for men

Surgeons should encourage men who request penile lengthening surgery to try non-invasive methods first and, in some cases, consider therapy to help them feel more positive about their body.

18 Apr 2011

Transgene, Inovio and ChronTech collaborate for novel vaccine phase I trial in HCV

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today it has signed a collaboration agreement with Transgene S.A. and ChronTech Pharma AB to evaluate a novel therapeutic vaccination strategy against genotype 1 hepatitis C virus in a phase I clinical study.

18 Apr 2011

Ascom to add alarm functionality to its i62 Protector for safe working environment

Ascom Wireless Solutions, the leading supplier of on-site wireless communications will add advanced alarm functionality to their VoWiFi handset, the Ascom i62 Protector, enabling personnel to feel secure when working in isolated environments or alone.

18 Apr 2011

Positive results from Nabriva's BC-3781 Phase II trial in ABSSSI

Nabriva Therapeutics today announced the successful results of a Phase II clinical trial of BC-3781 in acute bacterial skin and skin structure infections.

18 Apr 2011

CHMP adopts EU positive opinion for TYSABRI labeling with anti-JCV antibody status

Biogen Idec and Elan Corporation, plc today announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion for inclusion of an additional risk factor, anti-JC virus (JCV) antibody status, to the product label for TYSABRI in the European Union.

18 Apr 2011

DFG Senate Commissions propose statement on biobanks' legal regulations

Biomaterial banks are an indispensable resource for biomedical research. They are of great importance to the quality and competitiveness of German research. Therefore, it is important that clear strategies and recommendations exist for Germany. At present however, no general comprehensive statutory regulations, in the form of a research biobank act, should be introduced.

18 Apr 2011

Top-line results from Amarin's AMR101 Phase 3 trial in patients with high triglycerides

Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reported positive, statistically significant top-line results from its ANCHOR trial for the Company's lead product candidate, AMR101.

18 Apr 2011

Parents may chose predictive genetic tests for their children

Parents offered genetic testing to predict their risks of common, adult-onset health conditions say they would also test their children. That is the finding of a new study published in the May issue of Pediatrics.

18 Apr 2011

Medical News

Edgewater, Haldimand sign deal to acquire supply chain services from SSW

Flagship introduces end-to-end solutions for Medicare's reporting, recovery requirements

Idera's gene-silencing oligonucleotide studies published in Journal of Medicinal Chemistry

Amylin reports total revenue of $152.7 million for quarter ended March 31, 2011

FDA accepts Regeneron's VEGF Trap-Eye BLA for review

Prism Medical acquires Movement 2

iOWH's semisynthetic ART enters production, distribution phase to combat malaria

Nuvo Research to acquire ZARS Pharma

Biotech Synergy concludes EP-2101 asset transfer, cancer epitopes related portfolio

True 2 Beauty launches new sexual enhancement supplements

ETView Medical enters distribution agreement with Stopler Belgium

Study: Borna disease virus does not contain exact copies of genomic RNAs

Penile extenders represent an effective lengthening method for men

Transgene, Inovio and ChronTech collaborate for novel vaccine phase I trial in HCV

Ascom to add alarm functionality to its i62 Protector for safe working environment

Positive results from Nabriva's BC-3781 Phase II trial in ABSSSI

CHMP adopts EU positive opinion for TYSABRI labeling with anti-JCV antibody status

DFG Senate Commissions propose statement on biobanks' legal regulations

Top-line results from Amarin's AMR101 Phase 3 trial in patients with high triglycerides

Parents may chose predictive genetic tests for their children

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News